Over the past few weeks, the United Scientific Group and Cancer R&D-2020 committee members have been monitoring worldwide developments of coronavirus (COVID-19) outbreak. After careful consideration of the evolving concerns around COVID-19, and in alignment with the best practices laid out by the CDC, WHO, and other relevant entities. Subsequently and with a view of prioritizing the health and safety of our attendees, we have had to make what we feel is the positive step of taking Cancer R&D 2020 fully virtual on October 26-28, 2020.
The original program at the conference will be the same as much as possible. Our sincere thanks to our speakers, participants, sponsors, and exhibitors for your understanding, support, and flexibility.